Flynn James E 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-04 5:09 pm Sale |
2023-10-04 | 13G | Terns Pharmaceuticals, Inc. TERN |
Flynn James E | 0 0.000% |
-2,851,287 (Position Closed) |
Filing |
| 2023-02-10 3:57 pm Unchanged |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Flynn James E | 2,851,287 5.760% |
0 (Unchanged) |
Filing |
| 2022-12-23 3:35 pm Purchase |
2022-12-23 | 13G | Terns Pharmaceuticals, Inc. TERN |
Flynn James E | 2,851,287 5.940% |
991,287 (+53.30%) |
Filing |
| 2022-08-16 5:20 pm Sale |
2022-08-16 | 13G | Terns Pharmaceuticals, Inc. TERN |
Flynn James E | 1,860,000 4.940% |
-485,959 (-20.71%) |
Filing |
| 2022-02-11 4:15 pm Sale |
2021-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Flynn James E | 2,345,959 9.280% |
-36,074 (-1.51%) |
Filing |
| 2021-02-09 2:21 pm Purchase |
2021-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
Flynn James E | 2,382,033 9.940% |
2,382,033 (New Position) |
Filing |